Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

In vivo lineage labelling is better than in vitro methods for identifying and understanding stem cells.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Activating TSPO helps protect the retina from damage caused by high eye pressure in glaucoma.

Childhood ptosis can vary from a minor cosmetic issue to a serious condition and may signal other health problems.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Created microspheres show potential for safe and effective use in prostate artery embolization.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Alternative treatments show promise for hair growth beyond traditional methods.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Increasing PBX1 reduces aging and cell death in hair follicle stem cells by boosting SIRT1 and lowering PARP1 activity.

Nanoparticles show potential for controlled release of hair loss drugs, improving treatment effectiveness.

Dutasteride and finasteride affect different cell types differently.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Human skin's melanocytes respond to light by changing shape, producing pigments and hormones, which may affect sleep patterns.

Vitamin D3 may prevent hair loss from chemotherapy, but side effects and cancer cell protection are concerns.

Copper and iron cause keratin damage in hair by converting methionine to homocysteine.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Understanding and manipulating epigenetic changes can potentially lead to human organ regeneration therapies, but more research is needed to improve these methods and minimize risks.

A tough membrane between the outer and inner layers of human hair protects it from damage.

Polyphenols may help treat skin conditions like warts, hair loss, acne, and dark spots, but more research is needed.

Stress hormone CRF can cause hair loss by affecting hair growth cells and hormones.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

Sugar molecule helps hair growth, less in balding, returns with treatment.